Lilly Seeks Broader Mounjaro Use After It Helped Diabetic Kids

Sept. 17, 2025, 10:01 PM UTC

Eli Lilly & Co.’s Mounjaro helped kids as young as 10 control their blood sugar and lose weight in a study that may give doctors another tool to fight childhood diabetes.

The shot that’s been embraced by adult diabetics proved similarly beneficial for younger patients, reducing their blood sugar levels by an average of about 2%, according to results released at the European Association for the Study of Diabetes conference in Vienna. They also lost more than 10% of their body weight after a year of treatment.

Lilly said it’s submitted the results of the study involving about 100 ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.